You are here

HEMOCLEANSE, INC.

Company Information
Address
3601 SAGAMORE PARKWAY N, STE B
LAFAYETTE, IN 47904
United States



Information

DUNS:

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Pheresis Treatment of Bioterrorism-Induced Sepsis

    Amount: $1,011,540.00

    DESCRIPTION (provided by applicant): Victims of bacterial bioterrorism agents such as anthrax, plague, and tularemia die very often because of septicemia and subsequent multiple organ dysfunction synd ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  2. SUB-Q ULTRAFILTER/INFUSION DEVICE (SQUID) FOR INSULIN

    Amount: $100,000.00

    Not Available Painted coatings are not perfect and their integrity is constantly challenged. During everyday use, scratches or scribes are often introduced into a coating. Where this occurs, the unde ...

    SBIRPhase I1999Department of Health and Human Services
  3. DNA CHARCOAL PLASMA SORPTION FOR TREATMENT OF SLE

    Amount: $100,000.00

    N/A

    STTRPhase I1998Department of Health and Human Services
  4. BIOREACTOR WITH DIRECT PLASMA CONTACT FOR LIVER ASSIST

    Amount: $99,946.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
  5. Liver Assist by Push-Pull Sorbent-Regenerative Pheresis

    Amount: $100,000.00

    Acute hepatic failure (AHF) with Stage 4 coma is a serious illness with over 60% mortality when tresupportive therapy. The BioLogic-DT is an extracorporeal liver support device which uses the membranp ...

    SBIRPhase I1995Department of Health and Human Services
  6. Bioimpedance Control of Ultrafiltration on Hemodialysis

    Amount: $100,000.00

    We will apply thoracic electric bioimpedance monitoring by external electrodes (TEB) to those patieunstable on hemodialysis and find a primary cardiovascular parameter which predicts the onset of symO ...

    SBIRPhase I1995Department of Health and Human Services
  7. Enhancing Efficacy of Biologic-DT Liver Assist Device

    Amount: $54,000.00

    Acute hepatic failure (AHF) with Stage 4 coma is a serious illness with over 60% mortality whentreated with supportive therapy. The BioLogic-DT is an extracorporeal liver support device in whichblood ...

    SBIRPhase I1994Department of Health and Human Services
US Flag An Official Website of the United States Government